Dose inidividualization of antimicrobials based on population pharmacokinetic analysis in patients undergoing blood purification therapy

Dose inidividualization of antimicrobials based on population pharmacokinetic analysis in patients undergoing blood purification therapy - Dose inidividualization of antimicrobials based on population pharmacokinetic analysis in patients undergoing blood purification therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024321

Enrollment

120

Registered

2016-11-01

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Undergoing blood purification therapy

Exclusion criteria

Exclusion criteria: In state with impossible sampling of blood for measurement of blood antimicrobial concentration

Design outcomes

Primary

Measure	Time frame
To develop population pharmacokinetic model	—

Countries

Japan

Contacts

Public ContactKazutaka Oda

Kumamoto University Hospital Department of Pharmacy

kazutakaoda-kuh@umin.ac.jp096-373-7457

Outcome results